How much funding has Sequence Bio raised?

Sequence Bio has raised $3.9M in total funding, most recently a Seed round.

Who are Sequence Bio's investors?

Sequence Bio's investors include DCVC (Data Collab).

When was Sequence Bio founded?

Sequence Bio was founded in 2013.

Where is Sequence Bio headquartered?

Sequence Bio is headquartered in St. John's, Canada.

What industry is Sequence Bio in?

Sequence Bio operates in Drug Discovery, Genomics, Healthcare, Therapeutics.

How many employees does Sequence Bio have?

Sequence Bio has 51-200 employees.

Sequence Bio

Discovering the true signals of disease to power life-changing drugs.

St. John's, Canada · Founded 2013 · $3.9M raised

YC S19

Headquarters: St. John's
Employees: 51–200
Founded: 2013
Website: sequencebio.com

Total Funding: $3.9M
Last Round: $3.9M SeedAug 2016
Rounds: 1

About

90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.

Summary

Sequence Bio is a Drug Discovery company based in St. John's, Canada, founded in 2013. It has raised $3.9M in total across 1 round, most recently a $3.9M Seed round in Aug 2016. Investors include DCVC (Data Collab).